| Drug Name |
Aprepitant
|
||
| Synonyms |
Aprepitant [USAN]; L 754030; MK 0869; Emend (TN); L-754030; MK-0869; ONO-7436; Aprepitant (JAN/USAN/INN); MK-869, L-754030, Emend, Aprepitant; 3-(((2R,3S)-3-(p-Fluorophenyl)-2-(((alphaR)-alpha-methyl-3,5-bis(trifluoromethyl)benzyl)oxy)morpholino)methyl)-Delta(2)-1,2,4-triazolin-5-one; 3-(((2R,3S)-3-(p-Fluorophenyl)-2-(((alphaR)-alpha-methyl-3,5-bis(trifluoromethyl)benzyl)oxy)morpholino)methyl)-delta(sup 2)-1,2,4-triazolin-5-one; 5-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-1,2-dihydro-1,2,4-triazol-3-one; 5-[[(2S,3R)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-1,2-dihydro-1,2,4-triazol-3-one; 5-{[(2R,3S)-2-{(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}-3-(4-fluorophenyl)morpholin-4-yl]methyl}-2,4-dihydro-3H-1,2,4-triazol-3-one
|
||
| Drug Type |
Small molecular drug
|
||
| Indications |
Depression [ICD-11: 6A70-6A7Z]
|
Approved
|
|
|
Nausea [ICD-11: MD90]
|
Approved
|
||
|
Solid tumour/cancer [ICD-11: 2A00-2F9Z]
|
Phase 3
|
||
| Company |
Merck & Co
|
||
| Summary |
Aprepitant is a substance P/neurokinin 1 receptor antagonist used to treat nausea and vomiting caused by chemotherapy and surgery.
|
||
| Target |
Substance-P receptor (TACR1)
Mechanism of Action: Antagonist
|
T47094 | |
|
Formula |
C23H21F7N4O3
|
| Canonical SMILES |
CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NNC(=O)N3)C4=CC=C(C=C4)F
|
|
| InChI |
1S/C23H21F7N4O3/c1-12(14-8-15(22(25,26)27)10-16(9-14)23(28,29)30)37-20-19(13-2-4-17(24)5-3-13)34(6-7-36-20)11-18-31-21(35)33-32-18/h2-5,8-10,12,19-20H,6-7,11H2,1H3,(H2,31,32,33,35)/t12-,19+,20-/m1/s1
|
|
| InChIKey |
ATALOFNDEOCMKK-OITMNORJSA-N
|
|
| CAS Number | CAS 170729-80-3 | |
| TTD ID | D0GU4K | |
| DrugBank ID | DB00673 | |
| PubChem Compound ID | 135413536 | |
| PubChem Substance ID |
12015114
,
14787735
,
14812125
,
14861083
,
17194840
,
17397125
,
43529742
,
46505211
,
57371901
,
78987111
,
85688297
,
87325160
,
92309268
,
99004566
,
99436929
,
103537416
,
104093182
,
114787856
,
124757066
,
125163870
,
126591284
,
127455160
,
131407867
,
134340233
,
136920424
,
137218139
,
142087425
,
144115619
,
144241223
,
152034917
,
152108763
,
152258074
,
152344114
,
160646913
,
162011655
,
162037494
,
162180403
,
162802005
,
164831883
,
174527912
,
175268021
,
175611987
,
176484545
,
176484962
,
177749355
,
178100479
,
179150056
,
184816401
,
188899509
,
223704605
|
|
| ChEBI ID | CHEBI:499361 | |
| ADReCS Drug ID | BADD_D00157 |
| ID | Name | Dose | Type | Drug Brand Name | Drug Dose | Drug Dosage Form | Experimental Species | Individuals Number | Test Sample | Ingredient | Effect | Relationship Classification | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ID | Name | Dose | Type | Drug Brand Name | Drug Dose | Drug Dosage Form | Experimental Species | Individuals Number | Test Sample | Ingredient | Effect | Relationship classification |